Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection

NCT04627233 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shahid Beheshti University of Medical Sciences

Collaborators